Skip to main content

Bradley John Goldstein

Professor of Head and Neck Surgery & Communication Sciences
Rhinology and Skull Base Surgery
Duke South Yellow Zone #4000, DUMC Box 3805, Durham, NC 27710
40 Duke Medicine Circle, DUMC Box 3805, Durham, NC 27710

Current Appointments & Affiliations


Professor of Head and Neck Surgery & Communication Sciences · 2023 - Present Rhinology and Skull Base Surgery, Head and Neck Surgery & Communication Sciences
Professor of Cell Biology · 2023 - Present Cell Biology, Basic Science Departments
Professor in Neurobiology · 2023 - Present Neurobiology, Basic Science Departments

In the News


Published March 27, 2026
A Nasal Swab Test Could Change How Alzheimer’s is Detected
Published March 25, 2026
Duke Honors 38 Distinguished Professors in 2026
Published December 23, 2022
Scientists Find Key Reason Why Loss of Smell Occurs in Long COVID-19

View All News

Recent Publications


Olfactory cleft biopsy analysis of Alzheimer's disease pathobiology across disease stages.

Journal Article Nat Commun · March 18, 2026 Alzheimer's Disease (AD) is a neurodegenerative condition affecting millions worldwide. Defining early pathobiological events remains challenging, in part due to inaccessibility of neural tissue. Because olfactory neurons are accessible, and olfactory loss ... Full text Link to item Cite

Analysis of mucosal immune dysregulation and safety and tolerability of endoscopic topical steroid therapy for long-COVID hyposmia: randomized, double-blinded pilot study.

Journal Article Commun Med (Lond) · December 29, 2025 BACKGROUND: Millions of people exhibit olfactory dysfunction years after acute SARS-CoV-2 infection. Evidence suggests unresolved olfactory epithelial inflammation may perturb function. Here, we report (1) data from human olfactory biopsies processed for T ... Full text Link to item Cite

Adverse Effects of Dupilumab for Chronic Rhinosinusitis With Nasal Polyposis: Real-World Single Institution Experience.

Journal Article Laryngoscope · December 2025 OBJECTIVE: Phase III trials have shown that dupilumab is an effective and well-tolerated adjunct treatment for patients with uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP). However, real-world data pertaining to tolerability and adverse eff ... Full text Link to item Cite
View All Publications

Recent Grants


NEUROD1 and cell fate plasticity in olfactory neuroblastoma

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2026 - 2031

Towards a molecular biology of human olfaction in health and disease

ResearchPrincipal Investigator · Awarded by National Institute on Deafness and Other Communication Disorders · 2024 - 2029

University of Rochester R25

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by University of Rochester Medical Center · 2024 - 2029

View All Grants

Education


State University of New York Upstate Medical University · 1999 M.D.
State University of New York Upstate Medical University · 1999 Ph.D.
University of Virginia · 1992 B.A.